Data from: Safety and immunogenicity of H1/IC31?, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ Lymphocyte counts greater tha

负责人：

关键词：

DOI：

doi:10.5061/dryad.r61r8

摘要：

. In total, 459 mild or moderate and 2 severe adverse events were reported. There were three serious adverse events in two vaccinees classified as not relate

Data from: Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis

负责人：

关键词：

Checkpoint inhibitors;Immunotherapy-related adverse events;data analysis;Cancer Immunotherapy;Information extraction

DOI：

doi:10.5061/dryad.fg6kt38

摘要：

immune-related adverse events (irAEs) and the underlying biological mechanisms are not well-understood. To ensure safe cancer treatment, research efforts

Data from: First-in-human randomized controlled trial of an oral, replicating Adenovirus 26 vector vaccine for HIV-1

负责人：

关键词：

clinical trial;vaccine;phase 1;Adenoviridae;HIV;immune responses

DOI：

doi:10.5061/dryad.697r480

摘要：

and 4 participants received placebo. The vaccine caused only mild to moderate adverse events. No vaccine-related SAEs were observed. No infectious rcAd

Data from: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

负责人：

Diemert, David

关键词：

DOI：

doi:10.5061/dryad.1gr29

摘要：

adverse events being mild to moderate injection site pain and tenderness, and mild headache and nausea; no vaccine-related severe or serious adverse events wer

Data from: Immune checkpoint inhibitor–related myositis and myocarditis in patients with cancer

负责人：

关键词：

immune related adverse events;PD-L1;Muscle disease;CTLA-4;PD-1

DOI：

doi:10.5061/dryad.6r19m91

摘要：

Objective: To report the clinicopathological features and outcome of myositis in patients treated with immune checkpoint inhibitors (irMyositis

Data from: Neuromuscular adverse events associated with Anti-PD-1 monoclonal antibodies: systematic review

负责人：

关键词：

Immune checkpoint inhibitor;Myasthenia;Muscle disease;Autoimmune diseases;Peripheral neuropathy

DOI：

doi:10.5061/dryad.84q73s8

摘要：

Neuromuscular adverse events following cancer treatment with anti–programmed cell death protein 1 (PD-1) monoclonal antibodies are relatively rare

Data from: Effect of dimethyl fumarate on lymphocytes in RRMS: implications for clinical practice

负责人：

关键词：

Multiple Sclerosis;Clinical Trials

DOI：

doi:10.5061/dryad.n0cg254

摘要：

ng flow cytometry. For some patients, lymphocyte counts were assessed after DMF discontinuation. Incidence of adverse events, including ser